Transforming growth factor-β2 and TGF-β3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis

Developmental Dynamics

Volumn 219, Issue 2, 2000, Pages 237-247

  Opperman, Lynne A ^a   Adab, Katayoun ^a   Gakunga, Peter T ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

Apoptosis; Cell proliferation; Cranial vault; Craniosynostosis; Intramembranous bone growth; Rat; TGF 2; TGF 3

Indexed keywords

GROWTH FACTOR RECEPTOR; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE GROWTH; CALVARIA; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; DNA SYNTHESIS; DURA MATER; FACE DYSMORPHIA; FETUS; FRONTAL BONE; GENE MUTATION; GROWTH REGULATION; MORPHOGENESIS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT;

ANIMAL; ANTIBODIES; APOPTOSIS; CELL DIVISION; DNA; DURA MATER; GESTATIONAL AGE; MODELS, BIOLOGICAL; MORPHOGENESIS; ORGAN CULTURE; RATS; RATS, SPRAGUE-DAWLEY; SKULL; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; VERTEBRATA;

EID: 0033778791     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1044>3.0.CO;2-F     Document Type: Article

References (44)

1. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand
2. Patterns of growth of the skull as revealed by vital staining
3. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes
4. Sutural biology and the correlates of craniosynostosis
5. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis)
6. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific
7. Fibroblast growth factor receptor 3 is a negative regulator of bone growth
8. Mutations of the TWIST gene in the Saethre-Chotzen syndrome
9. Normal and abnormal patterns of craniofacial growth
10. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders
11. Fibroblast growth factor in chick osteogenesis
12. Fibroblast growth factor: Effects on osteogenesis and chondrogenesis in the chick embryo
13. Sutural morphogenesis in the mouse calvaria: The role of apoptosis
14. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras
15. Role of TGF beta s and BMPs as signals controlling the position of the digits and the areas of interdigital cell death in the developing chick limb autopod
16. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome
17. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2
18. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault
19. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2
20. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis
21. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development
22. Elevated levels of transforming growth factors beta 2 and beta 3 in lambdoid sutures from children with persistent plagiocephaly
23. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-mediated craniosynostosis in humans
24. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome
25. The molecular basis of Boston-type craniosynostosis: The Pro148→His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences
26. In vivo inhibition of programmed cell death by local administration of FGF-2 and FGF-4 in the interdigital areas of the embryonic chick leg bud
27. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats
28. FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: Evidence for missense changes, insertions, and a deletion due to alternative RNA splicing
29. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome
30. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
31. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3
32. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro
33. Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production
34. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro
35. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro
36. Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis
37. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures
38. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome
39. Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development
40. Apoptosis in murine calvarial bone and suture development
41. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion
42. Studies in cranial suture biology: I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion
43. Recombinant transforming growth factor type beta 3: Biological activities and receptor-binding properties in isolated bone cells
44. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome